NCT03521648

Brief Summary

This registry study aims to collect data on efficacy and safety of different treatments of benign prostatic enlargement (BPE) and lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH-LUTS).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
19mo left

Started Jul 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Jul 2017Dec 2027

Study Start

First participant enrolled

July 7, 2017

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 29, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 11, 2018

Completed
9.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

January 26, 2021

Status Verified

January 1, 2021

Enrollment Period

10.4 years

First QC Date

April 29, 2018

Last Update Submit

January 25, 2021

Conditions

Keywords

Prostatic Artery EmbolizationTransurethral Prostate ResectionTransurethral Electroresection of ProstateContact Laser Ablation of ProstateLaser Enucleation of ProstateOpen prostatectomy

Outcome Measures

Primary Outcomes (3)

  • Reduction of Lower Urinary Tract Symptoms

    Change of total score of International Prostate Symptoms Score (IPSS; range 0 points (no symptoms) to 35 points (severe symptoms))

    baseline to 1 year

  • Changes of free urinary flow rate

    Measurement of urinary stream (mL/s) by urinary flow rate measurement

    baseline to 1 year

  • Changes of post void residual urine

    Measurement of post void residual urine (mL) by transabdominal ultrasound

    baseline to 1 year

Secondary Outcomes (54)

  • Reduction of Lower Urinary Tract Symptoms

    baseline to 6 weeks

  • Reduction of Lower Urinary Tract Symptoms

    baseline to 12 weeks

  • Reduction of Lower Urinary Tract Symptoms

    baseline to 6 months

  • Reduction of Lower Urinary Tract Symptoms

    baseline to 2 years

  • Reduction of Lower Urinary Tract Symptoms

    baseline to 5 years

  • +49 more secondary outcomes

Study Arms (3)

PAE

Men with BPH - LUTS BPE who have opted for PAE and have consented to take part in the Register Study.

Procedure: PAE

TURP

Men with BPH - LUTS BPE who have opted for TURP and have consented to take part in the Register Study.

Procedure: TURP

Other

Men with BPH - LUTS BPE who have opted for other treatment options (e.g., holmium laser enucleation of the prostate, open prostatectomy, thulium laser vaporization, resection or enucleation, transurethral incision of the prostate) and have consented to take part in the Register Study.

Procedure: Other

Interventions

PAEPROCEDURE

Prostatic artery embolization

PAE
TURPPROCEDURE

Transurethral resection of the prostate

TURP
OtherPROCEDURE

Other surgical procedures for BPH treatment including holmium laser enucleation of the prostate, open prostatectomy, thulium laser vaporization, resection or enucleation, transurethral incision of the prostate

Other

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients treated for BPH / LUTS / prostatic obstruction at the urological department of KSSG

You may qualify if:

  • All patients treated for BPH / LUTS / prostatic obstruction at the urological department of KSSG
  • Patient age ≥ 18 years
  • Informed consent provided

You may not qualify if:

  • Cognitive impairment not allowing Informed Consent or adequate data assessment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Gallen Cantonal Hospital

Sankt Gallen, Canton of St. Gallen, 9007, Switzerland

RECRUITING

MeSH Terms

Conditions

Lower Urinary Tract SymptomsProstatic Hyperplasia

Interventions

Transurethral Resection of Prostate

Condition Hierarchy (Ancestors)

Urological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsProstatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

ProstatectomyUrologic Surgical Procedures, MaleUrologic Surgical ProceduresUrogenital Surgical ProceduresSurgical Procedures, Operative

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr. med. Dominik Abt

Study Record Dates

First Submitted

April 29, 2018

First Posted

May 11, 2018

Study Start

July 7, 2017

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

January 26, 2021

Record last verified: 2021-01

Locations